Top compounds associated with response to MADD


Feature Type Standardized
Nominal ANOVA
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA Vorinostat GDSC1000 pan-cancer AAC 0.16 6e-07
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.19 2e-06
mRNA GW-2580 GDSC1000 pan-cancer AAC 0.17 2e-06
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA PL-DI CTRPv2 pan-cancer AAC 0.15 4e-06
mRNA navitoclax:PLX-4032 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-06
mRNA methylstat CTRPv2 pan-cancer AAC 0.2 4e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 4e-06
Download CSV